Parkinson’s Patients at Greater Risk of Dying from COVID-19, Study Suggests
Parkinson’s disease patients have an increased risk of dying from COVID-19, a recent study suggests. This heightened risk may be due…
Articles by Diana Campelo Delgado
Caffeine May Protect Against Parkinson’s Due to LRRK2 Mutations
Caffeinated drinks like coffee may help to protect people from Parkinson’s disease caused by mutations in the LRRK2 gene, much as…
FDA Accepts New Drug Application for IRLAB’s Mesdopetam for Dyskinesia
The U.S. Food and Drug Administration (FDA) has accepted an investigational new drug application for mesdopetam (IRL790), an…
Parkinson’s May Have 2 Distinct Subtypes, Researchers Suggest
Parkinson’s disease can be characterized as two different subtypes: one that starts in the brain and one that starts…
Stem Cell Therapy Repairs Parkinson’s Degeneration in Mice, Study Shows
Human stem cells can repair Parkinson’s disease-damaged neural circuits and restore motor function in mice, a recent study…
Sudden Blood Pressure Drop Not an Early Marker of Parkinson’s, Study Finds
Orthostatic hypotension, a sudden drop in blood pressure when changing positions, can significantly affect both function and quality of…
$6M Grant Awarded for Research Into Role of Aging in Parkinson’s
The Aligning Science Across Parkinson’s initiative has awarded a $6 million grant to a research team…
Scientists Develop New System to Better Manage Medication Delivery
Scientists have developed a new system that can provide a controlled and sustained release of parkinsonian medications, thus enabling better…
$7.2M Grant Advances Work Into LRRK2 Protein’s Role in Parkinson’s
The Aligning Science Across Parkinson’s (ASAP) initiative has awarded a $7.2 million grant to a research team working to unravel…
Reduced Protein Synthesis May Be Early Indicator for Parkinson’s
Reduced protein synthesis could serve as a biomarker to help diagnose Parkinson’s disease, even before motor symptoms appear, a…